Literature DB >> 31121199

Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis.

Francesco Bartoli1, Cristina Crocamo2, Giuseppe Carrà3.   

Abstract

We aimed at clarifying the strength and consistency of the association between cannabis use disorder and suicide attempts in bipolar disorder. We conducted a systematic review and meta-analysis of observational studies providing cross-sectional and longitudinal data on this association. We screened articles indexed in Medline, Embase, PsycINFO databases up to July 2018. The random-effects meta-analysis, based on 6375 subjects from eleven studies, estimated a cross-sectional association between cannabis use disorder and history of suicide attempts (OR = 1.35; p = 0.01; I2 = 41.7%). Meta-regression analyses showed that effect size was not influenced by any study characteristics. Publication bias was not detectable. We could not perform a meta-analysis exploring the longitudinal association between cannabis use disorder and suicide attempts, due to the lack of suitable data. The current evidence highlights a weak association between cannabis use disorder and suicidal attempts in bipolar disorder. Due to the cross-sectional design of included studies, causal inferences could not be explored.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Cannabis; Meta-analysis; Suicide

Mesh:

Year:  2019        PMID: 31121199     DOI: 10.1016/j.neubiorev.2019.05.017

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  7 in total

1.  Cannabidiol for Mood Disorders: A Call for More Research.

Authors:  Francesco Bartoli; Bianca Bachi; Angela Calabrese; Federico Moretti; Cristina Crocamo; Giuseppe Carrà
Journal:  Can J Psychiatry       Date:  2020-05-14       Impact factor: 4.356

2.  Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders.

Authors:  James J Prisciandaro; William Mellick; Lindsay M Squeglia; Sara Hix; Lauren Arnold; Bryan K Tolliver
Journal:  Addict Biol       Date:  2021-08-14       Impact factor: 4.093

Review 3.  Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.

Authors:  Lauren Kuhns; Emese Kroon; Karis Colyer-Patel; Janna Cousijn
Journal:  Psychopharmacology (Berl)       Date:  2021-11-06       Impact factor: 4.415

4.  The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites.

Authors:  Francesco Bartoli; Błażej Misiak; Tommaso Callovini; Daniele Cavaleri; Riccardo M Cioni; Cristina Crocamo; Jonathan B Savitz; Giuseppe Carrà
Journal:  Mol Psychiatry       Date:  2020-10-19       Impact factor: 15.992

5.  The Use of Non-Prescribed Prescription Drugs and Substance Use Among College Students: A 9-Year Follow-Up Cohort Study.

Authors:  Alicia Busto Miramontes; Lucía Moure-Rodriguez; Ainara Diaz-Geada; Carina Carbia; Fernando Cadaveira; Francisco Caamaño-Isorna
Journal:  Front Psychiatry       Date:  2020-08-27       Impact factor: 4.157

6.  Pre-Discharge Predictors of 1-Year Rehospitalization in Adolescents and Young Adults with Severe Mental Disorders: A Retrospective Cohort Study.

Authors:  Francesco Bartoli; Daniele Cavaleri; Federico Moretti; Bianca Bachi; Angela Calabrese; Tommaso Callovini; Riccardo M Cioni; Ilaria Riboldi; Renata Nacinovich; Cristina Crocamo; Giuseppe Carrà
Journal:  Medicina (Kaunas)       Date:  2020-11-15       Impact factor: 2.430

7.  Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMC Public Health       Date:  2020-11-04       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.